Joann Miller
Overview
Explore the profile of Joann Miller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
318
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jang B, Amirshaghaghi A, Choi J, Miller J, Issadore D, Busch T, et al.
ACS Nano
. 2025 Jan;
19(1):1794-1808.
PMID: 39749910
Nanoparticles have gained attention as drug delivery vehicles for cancer treatment, but often struggle with poor tumor accumulation and penetration. Single external magnets can enhance magnetic nanoparticle delivery but are...
2.
Tian Y, Carrillo-Malani N, Feng K, Miller J, Busch T, Sundaram K, et al.
Nanotheranostics
. 2024 Jan;
8(1):100-111.
PMID: 38164502
Phthalocyanine (PC) and naphthalocyanine (NC) dyes have long garnered interest as theranostic agents for optical imaging and phototherapy due to their near-infrared absorbance, photostability, imaging contrast, and proven safety in...
3.
Zappala F, Higbee-Dempsey E, Jang B, Miller J, Yan L, Minutolo N, et al.
Sci Adv
. 2022 May;
8(18):eabn4613.
PMID: 35522741
Extensive antibody engineering and cloning is typically required to generate new bispecific antibodies. Made-to-order genes, advanced expression systems, and high-efficiency cloning can simplify and accelerate this process, but it still...
4.
Higbee-Dempsey E, Amirshaghaghi A, Case M, Miller J, Busch T, Tsourkas A
Adv Ther (Weinh)
. 2022 May;
2(9).
PMID: 35494480
Traditional oncology treatment modalities are often associated with a poor therapeutic index. This has driven the development of new targeted treatment modalities, including several based on the conversion of optical...
5.
Carter S, Miller J, Cramer G, Yuan M, Guzman S, Putt M, et al.
Photochem Photobiol
. 2021 Jul;
98(1):117-126.
PMID: 34224156
Treatment de-escalation is sought in the management of precursor lesions of early stage breast cancer, driving the appeal of adjuvant modalities to lumpectomy that reduce toxicity and minimally detract from...
6.
Rubtsova N, Hart M, Arroyo A, Osharovich S, Liebov B, Miller J, et al.
Bioconjug Chem
. 2021 Jun;
32(8):1852-1863.
PMID: 34139845
New exogenous probes are needed for both imaging diagnostics and therapeutics. Here, we introduce a novel nanocomposite near-infrared (NIR) fluorescent imaging probe and test its potency as a photosensitizing agent...
7.
Teng C, Amirshaghaghi A, Cho S, Cai S, De Ravin E, Singh Y, et al.
J Neurooncol
. 2020 Sep;
149(2):243-252.
PMID: 32914293
Introduction: Glioblastoma multiforme (GBM) is the most common primary intracranial malignancy; survival can be improved by maximizing the extent-of-resection. Methods: A near-infrared fluorophore (Indocyanine-Green, ICG) was combined with a photosensitizer...
8.
Ong Y, Miller J, Yuan M, Chandra M, Khatib M, Vinogradov S, et al.
Cancers (Basel)
. 2020 Jun;
12(6).
PMID: 32549354
Fluence rate is an effector of photodynamic therapy (PDT) outcome. Lower light fluence rates can conserve tumor perfusion during some illumination protocols for PDT, but then treatment times are proportionally...
9.
Yan L, Luo L, Amirshaghaghi A, Miller J, Meng C, You T, et al.
Bioconjug Chem
. 2019 Oct;
30(11):2974-2981.
PMID: 31661959
Photodynamic therapy (PDT) has attracted extensive attention in recent years as a noninvasive and locally targeted cancer treatment approach. Nanoparticles have been used to improve the solubility and pharmacokinetics of...
10.
Amirshaghaghi A, Yan L, Miller J, Daniel Y, Stein J, Busch T, et al.
Sci Rep
. 2019 Feb;
9(1):2613.
PMID: 30796251
Photodynamic therapy (PDT) is an approved modality for the treatment of various types of maligancies and diseased states. However, most of the available photosensitizers (PS) are highly hydrophobic, which limits...